Skip to main content
. 2016 Sep 15;39(11):1117–1127. doi: 10.1007/s40264-016-0455-4

Fig. 1.

Fig. 1

Process flow and main gaps identified for adverse drug event reporting across all settings. ADE adverse drug event, HCP healthcare provider, MFR manufacturer, NDC National Drug Code, PS primary suspect